Methadone and Alcoholism: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge …

Methadone And Alcoholism in the News

Methadone And Alcoholism: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge …
Lightlake recently acquired patents that will allow it to widen its product pipeline to address patients with addictions to opioid painkillers, methadone, cocaine and amphetamine. The Company anticipates launching a development program for each of …
Read more on MarketWatch (press release)

More Methadone And Alcoholism Information…